Trademark: 90579137
Status Date
Tuesday, December 12, 2023
Filing Date
Monday, March 15, 2021
Published for Opposition
Tuesday, May 17, 2022
5 Pharmaceutical and veterinary preparations for the treatment of tumors, pain, neurological diseases, liver disease, ophthalmologic diseases, pulmonary disease, renal diseases, and any other disease that is associated with the biologic action of Transforming Growth Factor beta (TGF-b) of the human body or of animals; sanitary preparations for medical purposes; liquids, solutions or active agents for use in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases, liver disease, ophthalmologic diseases, pulmonary disease, renal diseases, and any other disease that is associated with the biologic action of Transforming Growth Factor beta (TGF-b) of the human body or of animals
44 Medical services in the pharmaceutical field, namely, the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body; veterinary services in the field of the treatment of tumors, pain, neurological diseases and similar malfunctioning of animals; hygienic and beauty care for human beings or animals, using liquids, solutions or active agents in the cosmetic field, namely, the plastic surgery and anaplastic field or anti-aging treatment
42 Scientific and technological services, namely, research and design relating thereto in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animals; industrial analysis in the nature of testing pharmaceuticals to ensure compliance with industry standards; providing scientific research services in the fields of medicine, namely, research on tumor treatment, pain, neurological diseases and similar malfunctioning of the human body or of animals; design and development of computer hardware and software in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animals
Dec 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 12, 2023
Sou Extension 3 Granted
Dec 12, 2023
Sou Extension 3 Filed
Dec 12, 2023
Sou Teas Extension Received
Jun 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2023
Sou Extension 2 Granted
Jun 14, 2023
Sou Extension 2 Filed
Jun 14, 2023
Sou Teas Extension Received
Dec 10, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2022
Sou Extension 1 Granted
Dec 8, 2022
Sou Extension 1 Filed
Dec 8, 2022
Sou Teas Extension Received
Jul 12, 2022
Noa E-Mailed - Sou Required From Applicant
May 17, 2022
Official Gazette Publication Confirmation E-Mailed
May 17, 2022
Published For Opposition
Apr 27, 2022
Notification Of Notice Of Publication E-Mailed
Apr 13, 2022
Law Office Publication Review Completed
Apr 13, 2022
Assigned To Lie
Apr 11, 2022
Approved For Pub - Principal Register
Apr 11, 2022
Teas/Email Correspondence Entered
Apr 11, 2022
Correspondence Received In Law Office
Apr 11, 2022
Teas Response To Office Action Received
Oct 14, 2021
Notification Of Non-Final Action E-Mailed
Oct 14, 2021
Non-Final Action E-Mailed
Oct 14, 2021
Non-Final Action Written
Oct 14, 2021
Assigned To Examiner
Jun 14, 2021
New Application Office Supplied Data Entered
Mar 18, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
